Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins
- PMID: 25350695
- PMCID: PMC4220464
- DOI: 10.1038/ncomms6068
Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins
Abstract
Statins effectively lower LDL cholesterol levels in large studies and the observed interindividual response variability may be partially explained by genetic variation. Here we perform a pharmacogenetic meta-analysis of genome-wide association studies (GWAS) in studies addressing the LDL cholesterol response to statins, including up to 18,596 statin-treated subjects. We validate the most promising signals in a further 22,318 statin recipients and identify two loci, SORT1/CELSR2/PSRC1 and SLCO1B1, not previously identified in GWAS. Moreover, we confirm the previously described associations with APOE and LPA. Our findings advance the understanding of the pharmacogenetic architecture of statin response.
Conflict of interest statement
B.M.P. serves on the Data and Safety Monitoring Board of a clinical trial funded by the device manufacturer (Zoll LifeCor). N.P. and A.S. received funding from Pfizer for the extended follow-up of the ASCOT UK participants. D.I.C. and P.M.R. received research support for independent genetic analysis in JUPITER from AstraZeneca. F.N. and B.J.B. have employment, stock and stock options in AstraZeneca, a for-profit company engaged in the discovery, development, manufacture and marketing of proprietary therapeutics such as rosuvastatin, but do not consider that this creates any conflict of interest with the subject-matter of this publication. R.M.K. serves on the Merck Global Atherosclerosis Advisory Board. The remaining authors declare no competing financial interests.
Figures


References
-
- Davidson M. H. & Toth P. P. Comparative effects of lipid-lowering therapies. Prog. Cardiovasc. Dis. 47, 73–104 (2004). - PubMed
-
- Mangravite L. M., Thorn C. F. & Krauss R. M. Clinical implications of pharmacogenomics of statin treatment. Pharmacogenomics J. 6, 360–374 (2006). - PubMed
-
- Postmus I. et al. Pharmacogenetics of statins: achievements, whole-genome analyses and future perspectives. Pharmacogenomics 13, 831–840 (2012). - PubMed
-
- Chasman D. I. et al. Pharmacogenetic study of statin therapy and cholesterol reduction. JAMA 291, 2821–2827 (2004). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- PG/13/66/30442/BHF_/British Heart Foundation/United Kingdom
- RC2-GM092318/GM/NIGMS NIH HHS/United States
- HL080295/HL/NHLBI NIH HHS/United States
- HHSN268201100012C/HL/NHLBI NIH HHS/United States
- N01 HC-95169/HC/NHLBI NIH HHS/United States
- UL1RR025005/RR/NCRR NIH HHS/United States
- N02-HL-6-4278/HL/NHLBI NIH HHS/United States
- N01-HC-25195/HC/NHLBI NIH HHS/United States
- HL073410/HL/NHLBI NIH HHS/United States
- UL1 RR033176/RR/NCRR NIH HHS/United States
- G9521010/MRC_/Medical Research Council/United Kingdom
- R01 HL103612/HL/NHLBI NIH HHS/United States
- UL1 TR000445/TR/NCATS NIH HHS/United States
- HHSN268201100009I/HL/NHLBI NIH HHS/United States
- N01 HC085080/HL/NHLBI NIH HHS/United States
- UL1RR033176/RR/NCRR NIH HHS/United States
- UL1TR000124/TR/NCATS NIH HHS/United States
- N01 HC-95165/HC/NHLBI NIH HHS/United States
- G952010/MRC_/Medical Research Council/United Kingdom
- G0400126/MRC_/Medical Research Council/United Kingdom
- R01HL59367/HL/NHLBI NIH HHS/United States
- HHSN268201100010C/HL/NHLBI NIH HHS/United States
- UL1 RR025005/RR/NCRR NIH HHS/United States
- N01 AG062101/AG/NIA NIH HHS/United States
- HHSN268201100008C/HL/NHLBI NIH HHS/United States
- U01 HL080295/HL/NHLBI NIH HHS/United States
- N01 HC095169/HL/NHLBI NIH HHS/United States
- HHSN268201100008I/HL/NHLBI NIH HHS/United States
- HL085251/HL/NHLBI NIH HHS/United States
- HHSN268201100005G/HL/NHLBI NIH HHS/United States
- N01 HC085082/HL/NHLBI NIH HHS/United States
- U01-HG04603/HG/NHGRI NIH HHS/United States
- R01 HL068986/HL/NHLBI NIH HHS/United States
- R01 HL059367/HL/NHLBI NIH HHS/United States
- HHSN268201100007C/HL/NHLBI NIH HHS/United States
- HL105756/HL/NHLBI NIH HHS/United States
- RR-024156/RR/NCRR NIH HHS/United States
- HHSN268200800007C/HL/NHLBI NIH HHS/United States
- N01 HC085086/HL/NHLBI NIH HHS/United States
- R01 HL085251/HL/NHLBI NIH HHS/United States
- U19 HL065962/HL/NHLBI NIH HHS/United States
- N01 HC085083/HL/NHLBI NIH HHS/United States
- 2 UL1 TR000445/TR/NCATS NIH HHS/United States
- N01 HC-95168/HC/NHLBI NIH HHS/United States
- HHSN268201100011I/HL/NHLBI NIH HHS/United States
- P30 DK079637/DK/NIDDK NIH HHS/United States
- HHSN268201100011C/HL/NHLBI NIH HHS/United States
- R01 HL086694/HL/NHLBI NIH HHS/United States
- U01 HG004603/HG/NHGRI NIH HHS/United States
- DH_/Department of Health/United Kingdom
- UL1 RR024156/RR/NCRR NIH HHS/United States
- N01 HC-95164/HC/NHLBI NIH HHS/United States
- 085475/B/08/Z/WT_/Wellcome Trust/United Kingdom
- 1R01AG032098-01A1/AG/NIA NIH HHS/United States
- R01 HL087652/HL/NHLBI NIH HHS/United States
- N01-AG-1-2100/AG/NIA NIH HHS/United States
- HL087652/HL/NHLBI NIH HHS/United States
- UL1 TR000124/TR/NCATS NIH HHS/United States
- N01 AG062106/AG/NIA NIH HHS/United States
- HHSN268200625226C/PHS HHS/United States
- U01 HG004402/HG/NHGRI NIH HHS/United States
- HL068986/HL/NHLBI NIH HHS/United States
- N01 HC-95160/HC/NHLBI NIH HHS/United States
- R01 HL105756/HL/NHLBI NIH HHS/United States
- U01HG004402/HG/NHGRI NIH HHS/United States
- R01 AG032098/AG/NIA NIH HHS/United States
- P30 DK063491/DK/NIDDK NIH HHS/United States
- HHSN268200782096C/HG/NHGRI NIH HHS/United States
- HHSN268201100006C/HL/NHLBI NIH HHS/United States
- HHSN268201200036C/HL/NHLBI NIH HHS/United States
- 084727/Z/08/Z/WT_/Wellcome Trust/United Kingdom
- N01 HC-95167/HC/NHLBI NIH HHS/United States
- N01 HC025195/HL/NHLBI NIH HHS/United States
- R01HL087641/HL/NHLBI NIH HHS/United States
- N01 HC-95159/HC/NHLBI NIH HHS/United States
- N01 HC055222/HL/NHLBI NIH HHS/United States
- HHSN268201100005I/HL/NHLBI NIH HHS/United States
- N01 AG062103/AG/NIA NIH HHS/United States
- N01 HC085079/HL/NHLBI NIH HHS/United States
- N01 HC-95161/HC/NHLBI NIH HHS/United States
- R01 HL080295/HL/NHLBI NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
- N01 HC-95163/HC/NHLBI NIH HHS/United States
- U19 HL069757/HL/NHLBI NIH HHS/United States
- MR/K006584/1/MRC_/Medical Research Council/United Kingdom
- HHSN268201100009C/HL/NHLBI NIH HHS/United States
- HHSN268201100005C/HL/NHLBI NIH HHS/United States
- N01 HC-95166/HC/NHLBI NIH HHS/United States
- DK063491/DK/NIDDK NIH HHS/United States
- HHSN268201100007I/HL/NHLBI NIH HHS/United States
- UL1 RR024975/RR/NCRR NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- R01HL103612/HL/NHLBI NIH HHS/United States
- R01 AG023629/AG/NIA NIH HHS/United States
- R01 HL087641/HL/NHLBI NIH HHS/United States
- HL103612/HL/NHLBI NIH HHS/United States
- R01 HL073410/HL/NHLBI NIH HHS/United States
- AG023629/AG/NIA NIH HHS/United States
- R56 AG023629/AG/NIA NIH HHS/United States
- 085475/Z/08/Z/WT_/Wellcome Trust/United Kingdom
- N01 HC085081/HL/NHLBI NIH HHS/United States
- N01 HC-95162/HC/NHLBI NIH HHS/United States
- N01 HC095159/HC/NHLBI NIH HHS/United States
- R01HL086694/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous